AMETEK, Inc. (AME)

AMETEK reported record fourth-quarter and full-year 2025 results, with revenue up approximately 13.4% year-over-year and EPS beating consensus estimates. AMETEK acquired LKC Technologies, expanding AMETEK's medical devices footprint. Several analyst firms updated their ratings and price targets for AMETEK. The stock price reached new 52-week highs multiple times in early February 2026. Over the last 90 days, company insiders sold approximately 137,088 shares.

While specific product-level demand seasonality for AMETEK, Inc. is not explicitly detailed, the Industrials sector generally exhibits a period of seasonal strength from October 29 to May 10. Historically, AMETEK's stock has shown a seasonal tendency with a "Buy Date" of October 20 and a "Sell Date" of March 7. The company has also reported solid demand with overall orders growing, and a consistent positive book-to-bill ratio.

AMETEK, Inc. is a global designer and manufacturer of electronic instruments and electromechanical devices, serving diverse industries such as process, aerospace, medical, research, power, and industrial sectors. The company operates through two segments: the Electronic Instruments Group (EIG), which focuses on advanced analytical, test, and measurement instruments, and the Electromechanical Group (EMG), which specializes in electromechanical devices and related solutions.

AMETEK is a global company with operations spanning 30 countries and over 150 sites worldwide. While the majority of its sales are in the United States, the company maintains an expansive network of international offices, including significant operations in regions such as Asia and European Union countries.

AMETEK's brand reputation appears to be largely positive, driven by strong financial performance and strategic growth initiatives, such as the acquisition of LKC Technologies. There is no readily available information indicating specific events that have negatively impacted AMETEK, Inc.'s brand reputation in the past year.

The ownership structure of AMETEK, Inc. is primarily composed of institutional investors, individual investors, and company insiders. Institutional investors own approximately 50.70% to 89% of the company's stock. Public companies and individual investors collectively own about 48.98% of the stock. Company insiders own a smaller portion, around 0.33% to 0.66% of the company's stock.